BCDS (BCDS) Stock Price & Analysis
BCDS (BCDS) rose 8.50% to USD 0.03 as of July 25, 2026 at 13:41 UTC, according to Nexqual real-time market data.
BCDS last closed at USD 0.02; the session ranged USD 0.02–0.03 on volume of 1,931,721 shares. Market capitalization is $24.54M, with a 52-week range of USD 0–0.03 (OID). Source: Nexqual, July 25, 2026 at 13:41 UTC.
Key Statistics (as of July 25, 2026 at 13:41 UTC)
| Price | USD 0.03 |
|---|---|
| Change | ▲ 8.50% (up) |
| Previous Close | USD 0.02 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.03 |
| 52-Week Range | USD 0 – 0.03 |
| Volume | 1,931,721 shares |
| Market Cap | $24.54M |
| Exchange | OID |
Technical Analysis (BCDS)
Nexqual's technical model rates BCDS "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 13:41 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 66.98 (neutral) |
| vs SMA50 | Above (USD 0.02) |
| MACD | 0 (positive) |
Analyst Ratings (BCDS)
Wall Street analysts rate BCDS "None", per Nexqual as of July 25, 2026 at 13:41 UTC.
| Consensus Rating | None |
|---|
Earnings (BCDS)
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Financials & Fundamentals (BCDS)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -3.84% |
| Current Ratio | 297.24 |
| Total Cash | $114,051 |
| Total Debt | $0 |
| Free Cash Flow | $-100,930 |
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Financial Health Score (BCDS)
Nexqual rates BCDS's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:41 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $114K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$653K |
| Efficiency | Critical — ROE -4%, ROA -2.4% |
Ownership (BCDS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 915.81M |
Source: Nexqual, July 25, 2026 at 13:41 UTC.
Leadership (BCDS)
BCDS is led by Shannon Hill, CEO & President, per Nexqual as of July 25, 2026 at 13:41 UTC.
| CEO & President | Shannon Hill |
|---|---|
| Chief Marketing Officer | Nicholas Stover |
| Director of Sales | Kevin Sharpton |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PTKN | Primior Holdings Inc. | USD 0 | ▲ 12.5% |
| AAPJ | AAP, Inc. | USD 0 | ▲ 0% |
| AIMN | Aimwell Partners Inc. | USD 0 | ▼ 25% |
| CBIA | Canopus Biopharma, Inc. | USD 0 | ▲ 0% |
| ASII | Accredited Solutions Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:41 UTC. This page is informational and not investment advice.